Literature DB >> 16304422

Evaluation of hematopoietic stem cell donors.

Mary M Horowitz1, Dennis L Confer.   

Abstract

Donation of hematopoietic stem cells, either through bone marrow or peripheral blood collection, is a generally safe procedure for healthy donors. Serious adverse events are uncommon and death is exceedingly rare. Nevertheless, all donors must be carefully evaluated and fully informed prior to donation. This should be done by clinicians having good understanding of the potential physical and psychological complications of donation and the factors that may increase these risks. Additionally, donors and graft products must be evaluated for the potential to transmit infections and other diseases to the recipient and to satisfy an increasing number of national and international regulatory requirements. Donors must be able to provide informed consent without coercion or pressure. Special attention to the clinical, psychological and social needs of pediatric donors is necessary.

Entities:  

Mesh:

Year:  2005        PMID: 16304422     DOI: 10.1182/asheducation-2005.1.469

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  18 in total

1.  Making the case for private cord blood banking: mission failed! Comment to Hollands and McCauley, Stem Cell Rev and Rep 2009;5:195-203.

Authors:  Alexander H Schmidt; Alexander Platz; Claudia Rutt; Gerhard Ehninger
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

2.  Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation.

Authors:  M H Lee; J H Jang; H J Min; H I Jang; J H Nah; C J Lyu; K-S Han; J H Won; Y-H Lee; S Y Chong; Y C Mun; W S Lee; S J Kim; I Kim
Journal:  Bone Marrow Transplant       Date:  2016-11-07       Impact factor: 5.483

Review 3.  A review of the haematopoietic stem cell donation experience: is there room for improvement?

Authors:  A Billen; J A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

4.  Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.

Authors:  R N Lown; J Philippe; W Navarro; S M van Walraven; L Philips-Johnson; M Fechter; R Pawson; M Bengtsson; M Beksac; S Field; H Yang; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

Review 5.  Related hematopoietic cell donor care: is there a role for unrelated donor registries?

Authors:  C Anthias; S M van Walraven; B S Sørensen; G N de Faveri; M Fechter; J Cornish; A Bacigalupo; C Müller; M Boo; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

Review 6.  Hematopoietic stem cell donation.

Authors:  Shu-Huey Chen; Tso-Fu Wang; Kuo-Liang Yang
Journal:  Int J Hematol       Date:  2013-02-19       Impact factor: 2.490

Review 7.  Effects and safety of granulocyte colony-stimulating factor in healthy volunteers.

Authors:  Paolo Anderlini
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

8.  Severe events in donors after allogeneic hematopoietic stem cell donation.

Authors:  Joerg Halter; Yoshihisa Kodera; Alvaro Urbano Ispizua; Hildegard T Greinix; Norbert Schmitz; Geneviève Favre; Helen Baldomero; Dietger Niederwieser; Jane F Apperley; Alois Gratwohl
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

9.  Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

Authors:  Chloe Anthias; Bronwen E Shaw; Deidre M Kiefer; Jane L Liesveld; Jean Yared; Rammurti T Kamble; Anita D'Souza; Peiman Hematti; Matthew D Seftel; Maxim Norkin; Zachariah DeFilipp; Kimberly A Kasow; Muneer H Abidi; Bipin N Savani; Nirali N Shah; Paolo Anderlini; Miguel A Diaz; Adriana K Malone; Joerg P Halter; Hillard M Lazarus; Brent R Logan; Galen E Switzer; Michael A Pulsipher; Dennis L Confer; Paul V O'Donnell
Journal:  Biol Blood Marrow Transplant       Date:  2015-11-18       Impact factor: 5.742

Review 10.  Allogeneic peripheral blood stem cell collection as of 2008.

Authors:  Beverly Rhodes; Paolo Anderlini
Journal:  Transfus Apher Sci       Date:  2008-05-22       Impact factor: 1.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.